Vanderbilt Institute for Global Health (VIGH)

Sepsis trial ranked No. 1 on critical care website

A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.

Partnership enhances eye care for Ebola survivors in Liberia

Vanderbilt University School of Medicine (VUSM), the Vanderbilt Institute for Global Health (VIGH) and the Vanderbilt Eye Institute (VEI) have joined forces with partners in Liberia to strengthen medical education and increase access to ophthalmology care in the aftermath of the 2014-2015 West African Ebola epidemic that killed more than 11,000 people.

VIGH fellowship training program lands NIH renewal

The Vanderbilt Institute for Global Health (VIGH) has received a five-year, $4.66 million renewal grant from the National Institutes of Health (NIH) to continue a program established in 2012 with Emory, Cornell and Duke universities that is training the next generation of leaders in global health research.

Trevathan named director for the Vanderbilt Institute for Global Health

Edwin Trevathan, MD, MPH, a pediatric neurologist and epidemiologist who has previously held prominent university leadership positions at Washington University in St. Louis (director of Pediatric Neurology), St. Louis University (dean, School of Public Health) and Baylor University (Provost and Executive Vice President) as well as at the U.S. Centers for Disease Control and Prevention (CDC), has been appointed director of the Vanderbilt Institute for Global Health (VIGH), effective Jan. 1, 2018.

Team’s mobile app helping healthcare workers in Africa

A smartphone application called mUzima, developed for healthcare workers by Vanderbilt’s Martin Were, MD, MS, and his team, is catching on in eastern Africa.

VIGH receives federal grants to fight kidney disease

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

1 2 3 4 5